X4 Pharmaceuticals, Inc. (XFOR) — 分析师展望 / 分析师共识目标价为. 基于 13 位分析师评级, 共识为 看涨 — 12 买入, 1 持有.
分析师共识目标价为 $10.00, 上涨空间为 138.1% 相对于当前价格 $4.20.
分析师预估 每股收益(EPS)为 $-3.90 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.19 vs 预期 $-3.90 (超预期 +95.2%). 2025: 实际 $-1.87 vs 预期 $-2.04 (超预期 +8.2%). 分析师准确度: 0%.
XFOR 股票 — 12个月价格预测
$10.00
▲ +138.10% 上涨空间
平均目标价
Based on 13 Wall Street analysts offering 12-month price targets for X4 Pharmaceuticals, Inc., the price target is $10.00.
平均目标价相对最新价格 $4.20 变动 +138.10%。
XFOR 分析师评级
Buy
基于过去3个月内 13 位分析师对 X4 Pharmaceuticals, Inc. 的评级
EPS 预测 — XFOR
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.19
vs Est –$3.90
▲ 1,996.8% off
2025
Actual –$1.87
vs Est –$2.04
▲ 9.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — XFOR
92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.003B
vs Est $0.002B
▲ 14.0% off
2025
Actual $0.035B
vs Est $0.034B
▲ 2.5% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
